mTOR signaling in growth, metabolism and disease
Jordan Translational Medicine Lecture 2024: Registration and in-person event only
Michael N. Hall was born (1953) in Puerto Rico and grew up in South America (Venezuela and Peru). He received his Ph.D. from Harvard University and was a postdoctoral fellow at the Pasteur Institute (Paris, France) and the University of California, San Francisco. He joined the Biozentrum of the University of Basel (Switzerland) in 1987 where he is currently Professor and former Chair of Biochemistry.

Hall has won many prestigious prizes for his pioneering research such the Louis-Jeantet prize (2009) and Albert Lasker award (2017).

Hall is a leader in the fields of TOR signalling and cell growth control. In 1991, Hall and colleagues discovered TOR (Target of Rapamycin) and subsequently elucidated its role as a central controller of cell growth and metabolism. TOR plays a key role in development and ageing, and is implicated in various disorders including cancer, cardiovascular disease, diabetes, and obesity.
Date: 28 November 2024, 13:00
Venue: MRC Weatherall Institute of Molecular Medicine, Headington OX3 9DS
Venue Details: WIMM Seminar Room
Speaker: Professor Michael Hall (University of Basel)
Organising department: MRC Molecular Haematology Unit
Organiser: Beatriz Hirt-Font (University of Oxford, MRC Weatherall Institute of Molecular Medicine)
Organiser contact email address: beatriz.hirt-font@imm.ox.ac.uk
Host: Prof Ketan Patel (University of Oxford)
Part of: Molecular Haematology Unit, WIMM
Booking required?: Required
Booking url: https://forms.office.com/Pages/ResponsePage.aspx?id=G96VzPWXk0-0uv5ouFLPka694m2YOtZAsAK8ItSHkOBUOVg5UjA0N1dNMUNMMk1IMlQ5VTJRQTg3Qy4u
Cost: Free
Audience: Members of the University only
Editor: Beatriz Hirt-Font